Skip to main content
. 2017 Jul 26;8(40):68472–68482. doi: 10.18632/oncotarget.19575

Table 2. Optimal cut-off values under 95% confidence interval for AJCC staging according to ROC curves analysis, with p values from direct comparison of ROC curves (only positive comparisons are shown).

AJCC stage Cut off value Sensitivity(%) (95% CI) Specificity(%) (95% CI) Pos LR(95% CI) Neg LR(95% CI) p value
D 0.749 × 10−3 mm2/s 73.9(58.9-85.7) 93.1(77.9-99.2) 10.72(2.8-41.3) 0.28(0.2-0.5)
f 0.145 76.1(61.24-87.4) 75.9(56.5-89.7) 3.15(1.6-6.1) 0.32(0.2-0.5)
D* 100.401 × 10−3 mm2/s 60.9(45.4-74.9) 96.6(82.2-99.9) 17.65(2.5-122.8) 0.41(0.3-0.6)
Ktrans 0.571 /min 97.8(88.5-99.9) 96.6(82.2-99.9) 28.37(4.1-194.7) 0.023(0.003-0.2) 0.0001a,b
Kep 0.8196 /min 91.3(79.2-97.6) 86.2(68.3-96.1) 6.62(2.7-16.5) 0.10(0.04-0.3)
Ve 0.6556 % 87.0(73.7-95.1) 89.7(72.6-97.8) 8.41(2.9-24.7) 0.15(0.07-0.3)
Vp 0.0757 % 84.8(71.1-93.7) 93.1(77.2-99.2) 12.29(3.2-47.1) 0.16(0.08-0.3)

* AJCC = American Joint Committee on Cancer; CI = confidence interval; Pos LR = positive likelihood ratio; Neg LR = negative likelihood ratio “a” = Ktrans vs f; “b” = Ktrans vs D*;

Bonferroni corrected p value = 0.002.